Mechanism of Action of Efinaconazole, a Novel Triazole Antifungal Agent
暂无分享,去创建一个
Y. Nishiyama | Yumi Kangawa | M. Nagashima | R. Pillai | T. Shibanushi | A. Iwata | Y. Tatsumi | F. Inui | William J Jo Siu | F. Inui | Yoshiyuki Tatsumi
[1] B. Elewski,et al. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies. , 2013, Journal of the American Academy of Dermatology.
[2] A. Fothergill,et al. Comparison of In Vitro Antifungal Activities of Efinaconazole and Currently Available Antifungal Agents against a Variety of Pathogenic Fungi Associated with Onychomycosis , 2013, Antimicrobial Agents and Chemotherapy.
[3] Xu Zhang,et al. Impact of pH on the antifungal susceptibility of vaginal Candida albicans , 2011, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[4] Clinical,et al. Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .
[5] L. W. Parks,et al. Biochemical and physiological effects of sterol alterations in yeast—A review , 1995, Lipids.
[6] H. Yamaguchi,et al. Effects of micafungin on the morphology of Aspergillus fumigatus. , 2005, Journal of electron microscopy.
[7] L. Meerpoel,et al. The Novel Azole R126638 Is a Selective Inhibitor of Ergosterol Synthesis in Candida albicans, Trichophyton spp., and Microsporum canis , 2004, Antimicrobial Agents and Chemotherapy.
[8] J. Maertens,et al. History of the development of azole derivatives. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[9] K. Kakehi,et al. Therapeutic Efficacy of Topically Applied KP-103 against Experimental Tinea Unguium in Guinea Pigs in Comparison with Amorolfine and Terbinafine , 2002, Antimicrobial Agents and Chemotherapy.
[10] H. Yamaguchi,et al. In Vitro Antifungal Activity of KP-103, a Novel Triazole Derivative, and Its Therapeutic Efficacy against Experimental Plantar Tinea Pedis and Cutaneous Candidiasis in Guinea Pigs , 2001, Antimicrobial Agents and Chemotherapy.
[11] D. Sheehan,et al. Current and Emerging Azole Antifungal Agents , 1999, Clinical Microbiology Reviews.
[12] S. Ishijima,et al. Structural Effects of Lanoconazole on the Hyphal Growth of Trichophyton rubrum. , 1996 .
[13] H. Yamaguchi,et al. Two mechanisms of butenafine action in Candida albicans , 1993, Antimicrobial Agents and Chemotherapy.
[14] J. Ortiz,et al. Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity. , 1992, Arzneimittel-Forschung.
[15] M. Osumi,et al. Effect of NND-318 on the Ultrastructure of Trichophyton mentagrophytes as Observed by Scanning and Transmission Electron Microscopy , 1991 .
[16] M. Borgers,et al. Degenerative changes in fungi after itraconazole treatment. , 1987, Reviews of infectious diseases.
[17] S. Gorman,et al. Effect of miconazole and clotrimazole on K+ release and inhibition of ergosterol biosynthesis in Trichophyton mentagrophytes and related ultrastructural observations. , 1986, The Journal of antimicrobial chemotherapy.
[18] L. W. Parks,et al. Multiple functions for sterols in Saccharomyces cerevisiae. , 1985, Biochimica et biophysica acta.
[19] N. Ryder,et al. Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans , 1984, Antimicrobial Agents and Chemotherapy.
[20] M. Osumi,et al. The effect of bifonazole on the structure of Trichophyton mentagrophytes. , 1984, Dermatologica.
[21] W. Beggs. Comparison of miconazole- and ketoconazole-induced release of K+ from Candida species. , 1983, The Journal of antimicrobial chemotherapy.